ArticleCJC pediatric and congenital heart disease2026
Outcomes of Cardiac Repair in Heterotaxy Syndrome Patients-Tertiary Center Experience.
Article in CJC pediatric and congenital heart disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to determine factors associated with poor outcomes and frequency of arrhythmia incidence in patients with heterotaxy syndrome (HS). Methods: A retrospective cohort study in a single tertiary center was conducted and included patients with operated HS between 2011 and 2020. A total of 52 patients were included. Relevant factors associated with mortality that were considered included univentricular (UV) or biventricular (BV) physiology, prematurity, low weight/age at surgery, the presence of atrioventricular valve regurgitation, anomalous pulmonary veins drainage, and type of atrial isomerism. Results: Thirty-three patients (63.4%) were diagnosed with left atrial isomerism (LAI), whereas the remaining 19 (36.5%) were diagnosed with right atrial isomerism (RAI). Thirty-eight patients (73%) underwent UV repair, whereas 14 patients (27%) had BV physiology. Patients were followed up for an average of 4.8 years. Lastly, 14 patients (27%) had died during the follow-up period. Notably, most patients with complete repair are among the LAI group, and high-grade heart block only occurred in patients with LAI. Moreover, patients with LAI were more likely to receive BV repair, whereas patients with RAI were more likely to undergo UV repair ( Conclusion: Managing HS patients with UV physiology still remains a challenge. Risk factors for mortality included lower initial operation age, and RAI approached significance. These data may assist with risk stratification and patient counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.